UroPharmacology

This presentation reviews pharmacologic options for managing lower urinary tract symptoms including overactive bladder dysfunction, stress urinary incontinence, and painful bladder syndrome. The presentation focuses on newer pharmacotherapeutic options and emerging pharmacologic targets.

Contact hours available until 3/7/2015.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Conflict of Interest Disclosure:
Planning Committee Disclosures:

Donna J. Carrico, WHNP, MS/ Consultant/Presenter Bureau: Uroplasty Inc.
Tamara Dickinson, RN, CURN, CCCN, BCB-PMD/ Advisory Board:Hollister Inc, Seek Wellness

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Non-Endorsement of Products:
Accreditation of activities for contact hours does not imply approval or endorsement of any product, advertising, or educational content by the Society of Urologic Nurses and Associates (SUNA) or the American Nurses Credentialing Center’s Commission on Accreditation.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Accreditation status does not imply endorsement by the provider or ANCC of any commercial product.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Objectives:

• Outline pharmacologic options for managing lower urinary tract symptoms.
• Describe newer pharmacotherapeutic options and emerging pharmacologic targets.